BDBM7115 3-Aminopyrazole deriv. 28::N-(5-Cyclopropyl-1H-pyrazol-3-yl)-2-[4-(5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)phenyl]propanamide::N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-[4-(5-oxo-4,5-dihydro-1H-1,2,4-triazol-4-yl)phenyl]propanamide
SMILES: CC(C(=O)Nc1cc(n[nH]1)C1CC1)c1ccc(cc1)-n1cn[nH]c1=O
InChI Key: InChIKey=DUXWDMGSXRPDFV-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyclin-Dependent Kinase 2 (CDK2) (Homo sapiens (Human)) | BDBM7115 (3-Aminopyrazole deriv. 28 | N-(5-Cyclopropyl-1H-py...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
Nerviano Medical Sciences | Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... | J Med Chem 48: 2944-56 (2005) Article DOI: 10.1021/jm0408870 BindingDB Entry DOI: 10.7270/Q2WQ020R | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (docked) |